Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A

Mahattanakul, W; Crawford, T O; Griffin, J W; Goldstein, J M; Cornblath, D R
February 1996
Journal of Neurology, Neurosurgery & Psychiatry;Feb1996, Vol. 60 Issue 2, p185
Academic Journal
journal article
No abstract available.


Related Articles

  • Apheresis in Chronic Inflammatory Demyelinating Polyneuropathy and in Renal Transplantation.  // Annals of Internal Medicine;Oct85, Vol. 103 Issue 4, p631 

    Deals with the use of apheresis in chronic inflammatory demyelinating polyneuropathy and in renal transplantation. Efficacy of apheresis in the treatment of chronic inflammatory demyelinating polyneuropathy; Possible uses for apheresis in renal transplantation.

  • Pharma: Clinic Roundup.  // BioWorld Today;3/27/2012, Vol. 23 Issue 59, p8 

    The article presents an update on clinical trials, including the Polyneuropathy and Treatment with Hezentra (PATH) study by CSL Behring to evaluate two different doses of subcutaneous immunoglobulin in the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).

  • CITATIONS AND CLINICIANS' NOTES: NERVE AND MUSCLE.  // Current Medical Literature: Neurology;2005, Vol. 21 Issue 2, p37 

    Discusses the abstract of the study "Treatment of Chronic Inflammatory Demyelinating Polyneuropathy With High-Dose Intermittent Intravenous Methylprednisolone," by G. Lopate and colleagues.

  • Alemtuzumab.  // Reactions Weekly;9/22/2012, Issue 1420, p6 

    The article describes the cases of three men who received alemtuzumab for chronic lymphocytic leukaemia (CLL) but developed acute inflammatory demyelinating polyneuropathy (AIDP) during treatment.

  • Methylprednisolone.  // Reactions Weekly;Jul2015, Vol. 1561 Issue 1, p124 

    An abstract of the article "Dramatic Improvement of Chronic Inflammatory Demyelinating Polyneuropathy Through Tenofovir Treatment in a Patient Infected with Hepatitis B Virus," by B. Aktas and colleagues is presented.

  • Alemtuzumab.  // Reactions Weekly;8/21/2010, Issue 1315, p8 

    The article describes the case of a man who developed autoimmune haemolytic anaemia after receiving treatment with intravenous alemtuzumab for chronic inflammatory demyelinating polyneuropathy.

  • polyneuropathy.  // Taber's Cyclopedic Medical Dictionary;2005, p1727 

    A definition of the term "polyneuropathy" is presented. It refers to any disease that affects multiple peripheral nerves. Definitions of different type of polyneuropathy including acute inflammatory polyneuropathy, amyloid polyneuropathy and chronic inflammatory demyelinating polyneuropathy are...

  • Chronic Inflammatory Demyelinating Polyneuropathy. Köller, Hubertus; Kieseier, Bernd C.; Jander, Sebastian; Hartung, Hans-Peter // New England Journal of Medicine;3/31/2005, Vol. 352 Issue 13, p1343 

    Discusses the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. Estimated incidence of inflammatory demyelinating polyneuropathy; Description of Guillain-Barr� Syndrome, an acute variant of inflammatory demyelinating polyneuropathy; Clinical signs and symptoms of...

  • Peginterferon-α-2b.  // Reactions Weekly;4/21/2012, Issue 1398, p34 

    The article describes the case of a 35-year-old man who developed chronic inflammatory demyelinating polyneuropathy (CIPD) during treatment with peginterferon-α-2b for chronic hepatitis C.

  • Chronic Inflammatory Demyelinating Polyneuropathy Possibly Associated with Tacrolimus. Haviv, Y.S.; Friedlaender, M.; Dranitzki-Elhallel, M. // Clinical Drug Investigation;1999, Vol. 18 Issue 2, p169 

    Presents the case study of a 62-year-old male diagnosed with chronic inflammatory demyelinating polyneuropathy possible associated with tacrolimus. Past medical history; Presenting signs and symptoms; Diagnostic procedures; Treatment.


Read the Article


Sign out of this library

Other Topics